The Impact of Pecs Blocks on Postmastectomy Pain Syndrome
NCT04586751
Anesthesia, Breast Cancer
Limassol, Cyprus
View Trial DetailsNCT Number: NCT03961269
This study is designed to evaluate the frequency and presentations of chronic persistent pain in patients after breast cancer surgery at our tertiary care hospital. Results of this study will help us to understand the magnitude of problem in our population and making institutional guidelines for appropriate management of such patients.
Looking for future studies?
Notify Me30 year–75 year
Female
Observational
After approval from the Departmental Research Committee and Institutional Ethical Review Committee all adult female patients with known carcinoma of breast who are scheduled for elective definitive breast cancer surgery (Mastectomy) from 1st July 2016 to 30th December 2016 will be enrolled in this audit. Inclusion of patients will be done once operative procedure is finalized and consent taken in breast clinic. Those patients who did not give consent and those patients who need reoperation on same side for recurrence of cancer or any reason will be excluded from this study.
Data will be obtained from patient's medical record, interview of patient on follow up visit at breast clinic and telephonic communication with patient. Variables have been defined and a special form has been designed for data collection. All patients will be followed for next three months and those who have persistent pain will be followed for six months after operation.
Follow up information will be obtained from patient visiting breast clinic. For any missing data patient's medical records will be reviewed and patient will be contacted to know if they have chronic post-surgical pain or not. Audit forms will be filled by authors according to their availability. The primary investigator or author at breast clinic will keep all forms for safe record keeping which shall later be used for data analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 to 6 months
After breast cancer surgery, patients were followed for next 3 months and those patients who developed persistent pain were followed for up to 6 months via pre designed questionnaire
Time frame: 3 to 6 months
After breast cancer surgery, patients were followed to observe the distribution and characteristics of pain on pre-designed questionnaire
Ali Sarfraz Siddiqui
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04586751
Anesthesia, Breast Cancer
Limassol, Cyprus
View Trial DetailsNCT06701019
Breast Cancer Female
Nottingham, Nottinghamshire, United Kingdom
View Trial DetailsNCT06636591
Breast Cancer Female, HER2-negative Breast Cancer
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05376644
Breast Cancer Female, Breast Diseases
Tomsk, Russia
View Trial Details